FDA Approves BREO® ELLIPTA® To Treat Adults With Asthma In The US
Asthma, News
GlaxoSmithKline and Theravance, Inc. recently announced that the FDA has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol ) as a once-daily treatment of asthma for patients aged 18 and older. However, Breo ... Read more